e-Edition
Obituaries
In Loving Memory
Magazines
Subscribe
Login to Comment
Register
jobs
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Life
Commentary
Contact
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Akoya BioSciences, Inc. - Common Stock
(NQ:
AKYA
)
2.490
-0.060 (-2.35%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Akoya BioSciences, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
Akoya Biosciences and NeraCare Enter into an Exclusive Global License Agreement for the Development and Commercialization of the Immunoprint Test for Early-Stage Melanoma Patient Treatment Decisions
December 10, 2024
Akoya expands clinical test menu, exclusively licensing the global rights to develop and commercialize NeraCare's Immunoprint test for prognostication of disease recurrence in early-stage melanoma...
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Nature Methods Names Spatial Proteomics "Method of the Year 2024" — Akoya Biosciences Celebrates Industry Milestone
December 09, 2024
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
A Closer Look at 4 Analyst Recommendations For Akoya Biosciences
August 06, 2024
Via
Benzinga
Analyst Scoreboard: 4 Ratings For Akoya Biosciences
June 03, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
November 15, 2024
Via
Benzinga
Akoya Biosciences Reports Third Quarter 2024 Financial Results
November 14, 2024
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya Biosciences Unveils a New Era in Spatial Content Innovation with the PhenoCode™ Discovery IO60 and Mouse FFPE IO Panel
November 05, 2024
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya Bioscience to Report Third Quarter 2024 Financial Results on November 14, 2024
October 28, 2024
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Earnings Scheduled For November 14, 2024
November 14, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 09, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
October 07, 2024
Via
Benzinga
Akoya’s Leading Spatial Proteomics Platforms Selected for Use by Ground-Breaking UK-Based MANIFEST Consortium to Revolutionize Cancer Immunotherapy
October 07, 2024
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya Biosciences Announces Scott Mendel as Chairman of the Board of Directors
October 03, 2024
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
AKYA Stock Earnings: Akoya Biosciences Meets EPS, Misses Revenue for Q2 2024
August 05, 2024
AKYA stock results show that Akoya Biosciences met analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Akoya Biosciences Reports Second Quarter 2024 Financial Results
August 05, 2024
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya Biosciences to Report Second Quarter 2024 Financial Results on August 5, 2024, and Participate at Two Upcoming Investor Conferences
July 15, 2024
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
May 14, 2024
Via
Benzinga
Why Alibaba Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
May 14, 2024
Via
Benzinga
Why Alcon Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
May 14, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
May 14, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
May 14, 2024
Pre-market stock movers are worth diving into as we check out all of the hottest news affecting shares on Tuesday morning!
Via
InvestorPlace
AKYA Stock Earnings: Akoya Biosciences Misses EPS, Misses Revenue for Q1 2024
May 13, 2024
AKYA stock results show that Akoya Biosciences missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
May 13, 2024
Via
Benzinga
Akoya Biosciences Reports First Quarter 2024 Financial Results
May 13, 2024
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya Biosciences and NeraCare Enter into an Exclusive Agreement to Enable Personalized Therapy Selection for Early-Stage Melanoma Patients
May 09, 2024
Leveraging Akoya’s market-leading PhenoImager HT platform and clinical development expertise with NeraCare’s Immunoprint test and best-in-class clinical data, the partnership will focus on increasing...
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya Biosciences Opens Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts
May 06, 2024
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical Workflows
May 02, 2024
KR-HT5 is based on Akoya’s PhenoImager® HT Platform
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024
April 22, 2024
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale
April 05, 2024
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
AKYA Stock Earnings: Akoya Biosciences Beats EPS, Beats Revenue for Q4 2023
March 04, 2024
AKYA stock results show that Akoya Biosciences beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
wpDiscuz
Insert